About US
Contact us
-
GSK taps NASCAR favorite to drive awareness of new Nicorette lozengeNASCAR driver Dale Earnhardt Jr. is taking the wheel for GlaxoSmithKline’s new Nicorette innovation—a better-tasting ice mint lozenge. The campaign, “Taste Test Drive,” features Earnhardtdriving and2019/7/1
-
Novartis' Gilenya staves off generic challengers—for now—after federal injunctionNovartis’ multiple sclerosismed Gilenya is facing U.S. generic challengers on all sides to its blockbuster sales,and the company hoped a court order could stave them off. The Swiss drugmaker got what2019/6/28
-
Sanofi and Regeneron's Dupixent scores 3rd FDA approval in sinusitis with nasal polypsSanofi and Regeneron’s Dupixent has been charging ahead since its initial approval in moderate-to-severe atopic dermatitis, later picking up a follow-up nod in moderate-to-severe asthma. Wednesday,2019/6/28
-
Analysts rip into AbbVie, Allergan's $63B deal, citing culture clash, strategy concerns and moreAbbVie made a major splash Tuesdaywith its proposed $63 billionbuyoutof Allergan that’ll create a top-5 pharma giant. But analysts and investors were hardly impressed. One day after the announcemen2019/6/27
-
FDA fast-tracks BI, Lilly's Jardiance in chronic heart failureWhen Boehringer Ingelheim and Eli Lilly’s diabetes med Jardiance first showed CV benefits in trial patients, it changed the game for the SGLT2 inhibitor class. Now, not content to reston its laurels,2019/6/26
-
Novartis manufacturing agreement cited in Syria controversyNovartis has found itself caught up in a controversy about ingredients shipped to Syria that critics say could have been used to make sarin gas. The report from Swiss media focused on German chemical2019/6/26
-
After Roche, BMS surprises, what does AbbVie need to do to win FTC clearance for Allergan buy?With mergers and acquisitions come antitrust reviews. And withthe U.S. Federal Trade Commission (FTC) cracking down on pharma deals these days, it’s only natural to ask whether AbbVie’s proposed $632019/6/25
-
On the road: Acadia teams up with Michael J. Fox Foundation for local, patient-focused Parkinson's eventsAcadia Pharmaceuticals is taking Parkinson’s disease education on the road in a partnership with the Michael J. Fox Foundation. The “Parkinson’s IQ + You”serieswill traverse the country through this2019/6/25
-
Former Pfizer site in Puerto Rico picked up by medical marijuana producerLooks like unloading surplus manufacturing sites to the cannabis industry is turning into a budding business for pharma. At the same time Novartis was negotiating a deal to sell a Colorado plant to a2019/6/24
-
Lilly enlists patients to raise cluster headache awareness after Emgality scores second nodCluster headache pain is so intense, one patient describes banging his head against the refrigerator door to make it stop. And he's justone of severalpatientsdescribing the agitating pain of episodic2019/6/24